Chemours (CC) Tops Q2 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
The Chemours Company Reports Second Quarter 2020 Results
July 30, 2020 4:15 PM EDTWILMINGTON, Del., July 30, 2020 /PRNewswire/ --Â The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Fluoroproducts, Chemical Solutions and Titanium Technologies, today announced its financial results for the second quarter 2020.
Second Quarter 2020 Highlights
Net Sales of $1.1 billion Net Income of $24 million, with EPS of $0.15 Adjusted Net Income of $30 million, with Adjusted EPS of $0.18 Adjusted EBITDA of $166 million Free Cash Flow of $50 million, a $167 million improvement from prior year On July 29th, the... More